Newman Dignan & Sheerar, Inc. - OVID THERAPEUTICS INC ownership

OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 91 filers reported holding OVID THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.05 and the average weighting 0.1%.

Quarter-by-quarter ownership
Newman Dignan & Sheerar, Inc. ownership history of OVID THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$54,192
+35.3%
16,522
+6.4%
0.02%
+30.8%
Q1 2023$40,047
+38.7%
15,5220.0%0.01%
+30.0%
Q4 2022$28,871
-0.4%
15,5220.0%0.01%
+100.0%
Q3 2022$29,000
-40.8%
15,5220.0%0.01%
-44.4%
Q1 2022$49,000
-2.0%
15,5220.0%0.01%
-40.0%
Q4 2021$50,000
-3.8%
15,5220.0%0.02%0.0%
Q3 2021$52,000
-29.7%
15,522
-16.2%
0.02%
-44.4%
Q1 2021$74,00018,5220.03%
Other shareholders
OVID THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
AWH Capital, L.P. 230,000$407,0000.69%
BVF INC/IL 3,293,000$5,829,0000.65%
COWEN INC. 1,101,414$1,950,0000.21%
ARMISTICE CAPITAL, LLC 1,780,000$3,151,0000.17%
Granite Point Capital Management, L.P. 417,857$740,0000.07%
Redmile Group, LLC 737,550$1,305,0000.04%
Tekla Capital Management LLC 496,977$880,0000.04%
Fairpointe Capital LLC 101,000$179,0000.01%
Alyeska Investment Group, L.P. 225,000$398,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 84,440$149,0000.00%
View complete list of OVID THERAPEUTICS INC shareholders